Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species

被引:609
作者
Ma, Ping'an [1 ]
Xiao, Haihua [2 ]
Yu, Chang [1 ,3 ]
Liu, Jianhua [4 ,5 ]
Cheng, Ziyong [1 ]
Song, Haiqin [1 ]
Zhang, Xinyang [1 ]
Li, Chunxia [1 ]
Wang, Jinqiang [6 ,7 ]
Gu, Zhen [6 ,7 ]
Lin, Jun [1 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Changchun 130022, Peoples R China
[2] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Jilin Univ, Hosp 2, Dept Radiol, Changchun 130041, Peoples R China
[5] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, Changchun 130012, Peoples R China
[6] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA
[7] North Carolina State Univ, Raleigh, NC 27695 USA
基金
中国国家自然科学基金;
关键词
Drug delivery; cisplatin; iron oxide; Fenton's reaction; reactive oxygen species; MOTEXAFIN GADOLINIUM; DELIVERY; DRUG; PRODRUG; MECHANISMS; RESISTANCE; NANOPARTICLES; INFLAMMATION; ARTEMISININS; OTOTOXICITY;
D O I
10.1021/acs.nanolett.6b04269
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Reactive oxygen species (ROS) plays a key role in therapeutic effects as well as side effects of platinum drugs. Cisplatin mediates activation of nicotinamide adenine dinudeotide phosphate (NADPH) oxidase (NOX), which triggers oxygen (O-2) to superoxide radical (O-2(center dot-)) and its downstream H2O2. Through the Fenton's reaction, H2O2 could be catalyzed by Fe2+/Fe3+ to the toxic hydroxyl radicals ((OH)-O-center dot), which cause oxidative damages to lipids, proteins, and DNA. By taking the full advantage of Fenton's chemistry, we herein demonstrated tumor site-specific conversion of ROS generation induced by released cisplatin and Fe2+/Fe3+ from iron-oxide nanocarriers with cisplatin(IV) prodrugs for enhanced anticancer activity but minimized systemic toxicity.
引用
收藏
页码:928 / 937
页数:10
相关论文
共 57 条
[51]   Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides [J].
Wu, Haohao ;
Yin, Jun-Jie ;
Wamer, Wayne G. ;
Zeng, Mingyong ;
Lo, Y. Martin .
JOURNAL OF FOOD AND DRUG ANALYSIS, 2014, 22 (01) :86-94
[52]   A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance [J].
Xiao, Haihua ;
Song, Haiqin ;
Yang, Qiang ;
Cai, Haidong ;
Qi, Ruogu ;
Yan, Lesan ;
Liu, Shi ;
Zheng, Yonghui ;
Huang, Yubin ;
Liu, Tongjun ;
Jing, Xiabin .
BIOMATERIALS, 2012, 33 (27) :6507-6519
[53]   Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II) [J].
Xiao, Haihua ;
Qi, Ruogu ;
Liu, Shi ;
Hu, Xiuli ;
Duan, Taicheng ;
Zheng, Yonghui ;
Huang, Yubin ;
Jing, Xiabin .
BIOMATERIALS, 2011, 32 (30) :7732-7739
[54]   Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug [J].
Xu, Xiaoyang ;
Xie, Kun ;
Zhang, Xue-Qing ;
Pridgen, Eric M. ;
Park, Ga Young ;
Cui, Danica S. ;
Shi, Jinjun ;
Wu, Jun ;
Kantoff, Philip W. ;
Lippard, Stephen J. ;
Langer, Robert ;
Walker, Graham C. ;
Farokhzad, Omid C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (46) :18638-18643
[55]   Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction [J].
Zhang, Chen ;
Bu, Wenbo ;
Ni, Dalong ;
Zhang, Shenjian ;
Li, Qing ;
Yao, Zhenwei ;
Zhang, Jiawen ;
Yao, Heliang ;
Wang, Zheng ;
Shi, Jianlin .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (06) :2101-2106
[56]   Tuning with pH: The selectivity of a new rhodamine B derivative chemosensor for Fe3+ and Cu2+ [J].
Zhang, Ling-Fei ;
Zhao, Jiang-Lin ;
Zeng, Xi ;
Mu, Lan ;
Jiang, Xue-Kai ;
Deng, Min ;
Zhang, Jian-Xin ;
Wei, Gang .
SENSORS AND ACTUATORS B-CHEMICAL, 2011, 160 (01) :662-669
[57]   The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice [J].
Zhang, Wei-Jian ;
Wei, Hao ;
Frei, Balz .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 235 (05) :633-641